Home » Topics » BioWorld Science

BioWorld Science
RSS

Altimmune demonstrates systemic antitumor activity with ALT-702 in preclinical study

Jan. 23, 2020

China's NMPA clears ASC-22 to begin trials for HBV in China

Jan. 23, 2020

Nubeqa approved in Japan for nonmetastatic castration-resistant prostate cancer

Jan. 23, 2020

DIRC3 acts as a tumor suppressor in melanoma

Jan. 23, 2020

FDA clears IND application for HEALEY ALS platform trial

Jan. 23, 2020

FDA clears IND for CYNK-001 in GBM

Jan. 23, 2020

AKCEA-APOCIII-LRx meets primary endpoint in phase II hypertriglyceridemia trial

Jan. 23, 2020

Leo Pharma discovers JAK1 inhibitors

Jan. 23, 2020

Incyte identifies PI3Kgamma inhibitors

Jan. 23, 2020

PTC Therapeutics discloses heteroaryl compounds for Huntington's disease

Jan. 23, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...